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A B S T R A C T
Colorectal carcinoma (CRC) is a major public health problem as the third leading malignant tumor in men and
fourth in women in Croatia. Prognosis and treatment greatly depend on tumor stage at the time of detection. Therefore,
the National Program of Colorectal Carcinoma Early Detection has been performed since 2007. The aim is to present the
response rate, colonoscopy findings and number of newly detected CRC cases in Brod-Posavina County. During five years
of the National Program performance, 28 CRC cases were detected in Brod-Posavina County, with the 3.3‰ rate of carci-
noma detection. The majority of CRC cases were found in the 50–64 age group. The response rate in the County was low
(20.4%), corresponding to the national rate but far from the recommended one. Such a result could be attributed to the
low level of awareness in the population at large, complex testing technique for general population, fear from disease de-
tection and from colonoscopy as a diagnostic procedure. Note should be made of the underestimated role of family physi-
cians; their involvement in the National Program should certainly result in better response rate in our County as well as
at the national level.
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Introduction
Colorectal cancer (CRC) is the third most prevalent
type of cancer in the world1. It is the third most common
malignant tumour in males and the fourth most common
malignancy in women in the Republic of Croatia2. Its
prognosis is closely related to the disease stage at the
time of diagnosis1. Clinical trials have demonstrated that
it is possible to reduce the incidence or improve cancer
survival through prevention and early detection3.
The European Union (2003) extended the recommen-
dation of implanting colorectal cancer screening using
the fecal occult blood test (FOBT) in the population aged
between 50 and 74 years4. Four randomized clinical trials
have shown that annual or biannual screening with
guaiac-based tests (C-FOBT) reduces overall mortality
due to CRC by 16% and CRC incidence by 20% and 17%
respectively5. Colorectal cancer mortality has been de-
clining over the last two decades in Europe, particularly
in women, the trends being, however, different across
countries and age groups. In the European Union (EU),
between 1997 and 2007 mortality from colorectal cancer
declined by around 2% per year, from 19.7 to 17.4/
100,000 men (world standardized rates) and from 12.5 to
10.5/100,000 women. Persisting favorable trends were
observed in countries of western and northern Europe,
while there were more recent declines in several coun-
tries of Eastern Europe, including the Czech Republic,
Hungary and Slovakia particularly in women (but not
Romania and the Russian Federation). In 2007, a sub-
stantial excess in colorectal cancer mortality was still ob-
served in Slovakia, Hungary, Croatia, the Czech Republic
and Slovenia in men (rates over 25/100,000), and in Hun-
gary, Norway, Denmark and Slovakia in women (rates
over 14/100,000)6. Colorectal cancer (CRC) was the sec-
ond leading cause of cancer mortality in men (N=1063,
49.77/100,000), as well as women (N=803, 34.89/100,000)
in Croatia in 20097,8. The Croatian National CRC Scree-
ning Program was established by the Ministry of Health
and Social Welfare, and its implementation started in
September, 20079. CRC is a good candidate for screening,
because it is a disease with high prevalence, has recog-
nised precursors, and early treatment is beneficial10.
Benefits of screening include a modest reduction in colo-
rectal cancer mortality, a possible reduction in cancer in-
cidence through the detection and removal of colorectal
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adenomas, and potentially, the less invasive surgery that
earlier treatment of colorectal cancers may involve11.
The aim is to present the response rate, colonoscopy
findings and colorectal carcinoma (CRC) cases detected
during the first cycle of the National Program of Colorec-
tal Carcinoma Early Detection (Program) in the Brod-
-Posavina County 2007–2012.
Material and Methods
The Ministry of Health and Social Welfare launched
the National Program in September 2007. Public health
teams at county Institutes of Public Health were ap-
pointed local Program coordinators. In addition, Labora-
tory of Microbiology, County Institute of Public Health,
Department of Internal Medicine and Department of Pa-
thology, Forensic Medicine and Clinical Cytology, Gen-
eral Hospital »Dr. Josip Ben~evi}« from Slavonski Brod
were involved in Program implementation in the Brod-
-Posavina County. During the 5–year period (2007–2012),
a total of 49,855 planned calls for fecal occult blood test
(FOBT) were distributed in the County, according to in-
structions issued by the Ministry of Health and national
coordinators from the National Institute of Public
Health. The target population included all individuals
aged 50–74 of both sexes. They all received informative
material, questionnaire and three FOBT sets to their
home address and asked to send the completed tests and
filled in questionnaires by mail to the Laboratory of Mi-
crobiology, County Institute of Public Health. The guaiac
test consisting of the specially prepared stabilized paper
impregnated with natural guaiac resin and a reagent
containing hydrogen peroxide (<6%) and 75% denatured
ethyl alcohol in aqueous solution is analyzed at Labora-
tory of Microbiology by specialist in medical laboratory
diagnosis and microbiologist. Reliability of test result
mainly depends on proper preparation of the subject
tested. Test procedure is explained in test insert and re-
quires delay of testing during hemorrhoidal hemorrhage,
diarrhea, urinary tract hemorrhage or menstruation,
and avoiding taking more than 250 mg citrus fruits daily
(one orange contains 7–75 mg of vitamin C) for three
days before testing. Laboratory testing is performed by
use of a detection reagent applied onto test fields. Test
result is positive if blue color appears on the test field
upon adding the reagent. Test is read within 30 seconds
to 3 minutes. According to the manufacturer’s informa-
tion, sensitivity of the method is 96%; however, guaiac
test positivity in the population of asymptomatic subjects
is only 1–2%. Test results and questionnaires are then
forwarded from microbiology to public health workers to
be entered in the Ministry of Health software. In case of
positive FOBT, the public health team makes an appoint-
ment for colonoscopy at Department of Internal Medi-
cine, General Hospital »Dr. Josip Ben~evi}« in Slavonski
Brod, in order to detect the cause of bleeding. The notice
and instructions on preparation for colonoscopy are sent
to the positive subject’s home address, while respective
information on the examination is also sent to the sub-
ject’s general practitioner. On colonoscopy, material is
obtained for analysis and referred for histopathology to
verify the diagnosis. The rate of carcinoma detection was
calculated as the number of carcinoma detected per 1000
FOBT. Data on the response rate, colonoscopy findings
and CRC cases detected were analyzed by descriptive
methods using all monthly reports on the public health
team activities.
Results
A total of 49,855 persons born between 1937 and 1957
were invited for screening in Brod-Posavina County;
10,168 (20.4%) envelopes were returned, however, only
8443 (16.9%) of these with the test completed. Out of
8382 FOBTs received (there were 6 incorrect tests), 602
(7.2%) were positive. Of these 602 persons called for
colonoscopy, 478 persons presented for examination.
Twenty-eight CRC cases were confirmed by colonoscopy
(5.9% of subjects submitted to colonoscopy, 4.7% of FOBT
positive cases, or 0.33% of all subjects examined), yield-
ing a 3.3% rate of CRC detection. The number of invited
and responsive persons and the number of CRC detected
according to age groups are shown in Table 1, and colo-
noscopy findings in Table 2.
Discussion
All individuals aged 50–74 at an average risk of devel-
oping CRC are recommended to undergo FOBT (guaiac
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TABLE 1
THE NUMBER OF INVITED AND RESPONSIVE PERSONS AND NUMBER OF COLORECTAL CARCINOMA DETECTED
ACCORDING TO AGE GROUPS
Age groups Invited Responsive persons Completed FOBT FOBT (+) (–) CRC
50–54 13019 2344 (18.0%) 2206 108 2092 7
55–59 9128 2066 (22.6%) 1908 64 1798 7
60–64 8876 1961 (22.1%) 1539 92 1442 7
65–69 9573 2183 (22.8%) 1596 188 1404 5
70–74 9259 1614 (17.4%) 1194 150 1044 2
Total 49855 10168 (20.4%) 8443 602 7780 28
FOBT – fecal occult blood test, CRC – colorectal carcinoma
test) screening over 3-year cycle9,12. The anticipated cycle
length of 3 years was considerably prolonged, with the
initial invitation to testing completed by the end of 2012,
i.e. more than 5 years. A total of 49,855 persons were in-
vited for testing in Brod-Posavina County. Discrepancy
between the number of test envelopes returned and the
number of tests performed occurred because some per-
sons had died, moved elsewhere, lived abroad, etc. The
response rate of 20.4% was consistent with the average
national response rate of 19.9% reported in 2007 and
201113,14. A rate of 28.1% exceeding the national average
rate was recorded in Me|imurje County15. All these re-
sponse rates are by far lower than those recommended by
EU guidelines of 65% and even from the minimal accept-
able rate of 45%. In our County, there was no significant
age related difference in response (Table 1). Such a low
response rate may be ascribed to inadequate understand-
ing of the screening test instructions (how to perform
stool sampling, how to apply it onto the test card, how to
send it, and how to properly store the test during sam-
pling period), fear from positive finding and fear from
colonoscopy that follows testing, and general unaware-
ness of the CRC prevalence. In the County, 602 (7.2%)
positive tests have been identified to date, which is con-
sistent with EU guidelines for the first cycle of screening
(1.5–8.5%)12 (Table 1). We received 0.1% of incorrect
tests, which is also in line with EU guidelines (less than
1% desirable)12.
Development of CRC can be prevented by screening
programs in a population at a higher risk, in this case in-
dividuals of both sexes aged 50–74. The test used on
screening detects the majority of early CRC cases and ad-
vanced adenomas. Implementation of screening tests in
the target population reduces the incidence and mortal-
ity of the disease5. An increase in the incidence of carci-
noma is expected to be recorded in the first years of Na-
tional Program implementation. In Brod-Posavina Coun-
ty, the incidence of CRC in 2006 was 52.61/100,000; in
2007, 2008 and 2009 it was similar (58.84/100,000, 58.27/
100,000 and 58.84/100,000, respectively), showing an in-
creasing tendency compared with 2006. It continued in-
creasing in 2010 (64.49/100,000), as expected.
The screening test is available, acceptable by price,
noninvasive and simply applicable by the majority of
general population5. Considering the low response rate,
the question is whether it really is so simple. As men-
tioned above, the target population may in part have
quite a low level of literacy and education, thus they can-
not fully understand and follow the insert instructions,
and do not respond to the invitation for screening.
Testing for occult bleeding once a year combined with
occasional colonoscopy is a successful method of CRC
prevention16. According to the manufacturer’s instruc-
tions, the method sensitivity is high (96%); however, in
the population of asymptomatic individuals, guaiac test
shows positivity of only 2–5% (in our study 7.1%) and
1–2% of false-positive results. Test limitations in terms
of lower sensitivity generally refer to small size polyps
and early lesions, whereas some studies also pointed to
low sensitivity in detecting carcinomas located on distal
colon and higher sensitivity for carcinomas located on
left colon16. The specificity of guaiac test is low because
only 5–10% (in our study 4.9%) of tested subjects have
carcinoma related lesions, whereas all others are false-
-positive. Such a great number of false-positive subjects
is one of the test drawbacks and increases the price of
screening, since colonoscopy is regularly performed in
test positive subjects17,18. In spite of all these test short-
comings, controlled clinical trials have found periodical
testing for occult bleeding to lead to low but significant
reduction in CRC mortality by 15–18%. Due to the low
specificity of guaiac test, new tests for detection of occult
bleeding have been marketed, e.g., immunologic and
hemoporphyrin tests characterized by high sensitivity,
while low specificity remains a problem; therefore, guai-
ac test is still most frequently used on screening18.
As recommended, public health workers make an ap-
pointment for colonoscopy for all FOBT positive persons,
which can take up to one month due to the limited capac-
ity of Department of Internal Medicine, General Hospital
»Dr. Josip Ben~evi}« in Slavonski Brod. Our colleagues
from Me|imurje County are faced with a similar prob-
lem15. Colonoscopy was performed in 478 persons, al-
though appointment was made for 602 persons, yielding
a colonoscopy response rate of 79.4%, which is below the
acceptable rate according to EU guidelines12. Screening
confirmed 28 CRC cases (5.9% of those submitted to
colonoscopy, 4.7% of FOBT positive individuals and 0.3%
of all individuals included in the National Program). The
rate of CRC detection was 3.3‰, which falls within the
recommended range (1.2–9.5‰)12. Pathologic findings
accounted for 80.5% of all colonoscopy findings, predomi-
nated by polyps and diverticula (50.1% and 23.4%, re-
spectively) (Table 2).




Age groups Orderly Polyps Hemorrhoids Diverticula CRC Others
50–54 36 31 7 13 7 3
55–59 5 21 8 3 7 1
60–64 14 32 6 16 7 5
65–69 26 51 19 33 5 3
70–74 12 58 22 25 2 0
Total 93 193 62 90 28 12
At the national level, colonoscopy verified 77.5% of
pathologic findings, with colon polyps accounting for
38.5% of the findings13. Family physicians have not been
adequately involved in the screening, although they
should play a key role in motivating target population,
thus increasing the response rate. Our colleagues from
Osijek have demonstrated that a higher response rate
can be achieved with family physicians taking the central
role in the screening19. Dutch authors also report on the
higher response rate in the countries where family physi-
cians have been actively included in the National Pro-
grams20. The inadequate role of family physicians in our
country has also been described by the authors from
Me|imurje County. Screening can only prove efficient if
associated with an appropriately high rate of response1;
therefore, it is of paramount importance to undertake
due measures at the national level, which will lead to
such a result (promotion, health education, and involve-
ment of family physicians and visiting nurses). The coun-
tries where such national programs have not yet been in-
troduced point to the role and need of mass screening21
due to continuously rising incidence22,23, mortality and
detection of advanced stage carcinomas24, associated with
reduced therapeutic options and poorer disease progno-
sis. Screening with retesting has a major role in the de-
tection of polyps with a high rate of malignant alteration,
as well as of earlier stages of disease, as malignant trans-
formation may take even more than 10 years25.
Conclusion
The National Program of Colorectal Carcinoma Early
Detection is of major public health importance; however,
improvements are required at both local and national
level. It should be backed up by more aggressive mass
media promotion, health education of the population at
large, and inclusion of family physicians and visiting
nurses in order to ensure optimal response rate in the
target population. The Program software should also be
improved for better data evaluation and faster Program
performance. Satisfactory results can only be expected
when all the preset guidelines are fully met.
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NACIONALNI PROGRAM RANOG OTKRIVANJA RAKA DEBELOG CRIJEVA
U BRODSKO-POSAVSKOJ @UPANIJI (ISTOK HRVATSKE)
S A @ E T A K
Kolorektalni karcinom (CRC) predstavlja veliki javno zdravstveni problem, budu}i da je na 3. mjestu po zastuplje-
nosti malignih tumor kod mu{karaca, a na 4. mjestu kod `ena u Hrvatskoj. Prognoza i lije~enje uvelike ovise o stadiju u
kojem je tumor otkriven. Stoga se u Hrvatskoj od 2007. godine provodi Nacionalni program ranog otkrivanja raka
debelog crijeva i na{ cilj je u ovom radu prikazati odaziv, nalaze kolonoskopije i broj otkrivenih CRC u Brodsko-posav-
skoj `upaniji. Tijekom 5 godina provo|enja Nacionalnog programa u Brodsko-posavskoj `upaniji je otkriven 28 karci-
nom. Najve}i broj karcinoma je u dobnoj skupini od 50–64 godine. Stopa detekcije karcinoma je 3,3 ‰. Odaziv na razini
`upanije je nizak i iznosi 20,4% {to odgovara prosjeku u Hrvatskoj, ali je daleko od preporu~enog. Takav rezultat mo`e-
mo tuma~iti slabom prosvje}enosti populacije, kompliciranosti testa za op}u populaciju, strahom od bolesti i kolonosko-
pije kao pretrage. Naglasili bi da je uloga lije~nika obiteljske medicine neadekvatna, te da bi se njihovim uklju~ivanjem
u Nacionalni program mogli posti}i bolji rezultati na nivo na{e `upanije, a i Hrvatske.
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